Rising Kidney Disease Cases Fuel Demand for Nutritional Supplements Worldwide
The global Chronic
Kidney Disease (CKD) Nutritional Supplement Market is witnessing steady
growth, driven by the rising prevalence of kidney disorders, increasing
awareness of clinical nutrition, and growing demand for specialized medical
foods. Valued at US$ 3.3 billion in 2021, the market is projected to
expand at a CAGR of 4.3% from 2022 to 2031, exceeding US$ 5.0 billion
by 2031.
Chronic kidney disease has emerged as a significant global
public health concern, creating greater demand for nutritional products that
support patients in managing their condition. Vitamins, minerals, amino acids,
probiotics, prebiotics, and other specialized nutritional formulations are
increasingly incorporated into CKD dietary management under medical
supervision.
Rising CKD Prevalence Driving Market Growth
The increasing geriatric population and growing incidence of
diabetes, hypertension, and other chronic conditions are among the primary
factors supporting market expansion. Older adults are particularly vulnerable
to kidney-related disorders, increasing the need for specialized nutritional care.
According to estimates cited by the Centers for Disease
Control and Prevention (CDC), approximately 37 million adults in the United
States were living with CKD. This growing patient population is encouraging
healthcare providers and manufacturers to focus on nutritional solutions that
address the specific dietary requirements of kidney patients.
Furthermore, increasing awareness regarding medical foods
and the importance of nutritional management is creating new opportunities for
market participants. Healthcare professionals are emphasizing appropriate
dietary interventions to help patients maintain nutritional balance and improve
their quality of life.
Vitamin and Mineral Supplements Dominate Product Demand
Based on nutrition type, the vitamin and mineral supplements
segment accounted for a significant market share in 2021. Growing demand for
essential vitamins, including B-complex, vitamin C, and vitamin D, is
supporting segment growth.
Patients with CKD may experience nutritional deficiencies
due to dietary restrictions and changes in kidney function. Consequently,
medically supervised supplementation is becoming increasingly important.
Meanwhile, amino acid supplements, particularly alpha-ketoanalogues, are
gaining attention for their potential role in nutritional therapy for patients
with kidney disease.
Capsules and Enteral Nutrition Gain Traction
By dosage form, capsules held a leading share of the market
in 2021 due to their convenience, ease of administration, and widespread
availability. Their portability and familiar consumption format make them an
attractive option for patients requiring regular nutritional supplementation.
The enteral nutrition segment is also expected to register
notable growth during the forecast period. Specialized foods for medical
purposes administered through enteral feeding can help address nutritional
requirements among patients who cannot consume adequate nutrients orally. Their
potential to support clinical outcomes and reduce certain healthcare costs is
encouraging wider adoption.
Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84899
Asia Pacific Emerging as a Prominent Growth Market
North America dominated the global CKD nutritional
supplement market in 2021, supported by advanced healthcare infrastructure,
established market players, and greater awareness of kidney health management.
However, Asia Pacific is expected to offer substantial
growth opportunities through 2031. Rising healthcare expenditure, increasing
CKD prevalence, population aging, and expanding access to online healthcare and
nutritional products are contributing to regional market development. China and
India are particularly important markets due to their large populations and
growing demand for specialized healthcare products.
E-commerce platforms are further improving product
accessibility, allowing consumers to explore and purchase nutritional
supplements conveniently.
Competitive Landscape and Future Opportunities
Leading companies operating in the market include Abbott
Laboratories, Fresenius Kabi AG, Nestlé S.A., Danone S.A., Ajanta Pharma
Limited, Mankind Pharma Ltd., Hexagon Nutrition Limited, and RPG Life Sciences
Limited.
Market participants are focusing on product innovation,
strategic acquisitions, partnerships, and research and development to
strengthen their competitive positions. The growing demand for personalized
nutrition and specialized medical foods is also encouraging companies to
develop advanced formulations for different stages of kidney disease.
Conclusion
The global chronic kidney disease nutritional supplement
market is positioned for consistent growth through 2031. Increasing CKD
prevalence, rising geriatric populations, greater awareness of nutritional
management, and expanding e-commerce distribution channels are expected to
support market development. With the market projected to surpass US$ 5.0
billion by 2031, innovation in specialized nutritional products and expansion
into emerging economies will remain important growth strategies for industry
participants.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

0 comments:
Post a Comment